Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.00005 par value
-
Shares outstanding
-
6,002,966
-
Total 13F shares
-
157,266
-
Share change
-
+157,266
-
Total reported value
-
$36,709
-
Price per share
-
$0.23
-
Number of holders
-
4
-
Value change
-
+$36,709
-
Number of buys
-
4
Institutional Holders of BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) as of Q3 2024
As of 30 Sep 2024,
BRAINSTORM CELL THERAPEUTICS INC. - Common Stock, $0.00005 par value (BCLI) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
157,266 shares.
The largest 4 holders included
ABNER HERRMAN & BROCK LLC, Avior Wealth Management, LLC, ST GERMAIN D J CO INC, and Bogart Wealth, LLC.
This page lists
4
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.